Stem cell transplant
Mainly immunotherapy an drug development in hematological malignancies.
- Methods (Immunomodulation) to decrease graft versus host disease in the setting of hemotopoietic stem cell transplantation-at the bench and bedside.
- Epigenetic modulation of Natural Killer (NK) cells to enhance cytotoxicity towards tumor gargets at the bench and apply to adoptive infusion of NK cells as cancer treatments at bedside.
- Drug development in Lymphoma.